Evaluation of the Safety and Effectiveness of BELKYRA® Inj. for the Treatment of Patients with Submental Fullness due to Submental Fat: A Postmarketing Surveillance Study in Korea

30/08/2018
22/04/2026
EU PAS number:
EUPAS23762
Study
Finalised
Documents
Study protocol
Initial protocol
English (886.25 KB - PDF) View document
Study results
Study report
Abstract of study report
English (206.67 KB - PDF) View document
Other information